RenaissThera is a privately held biotechnology company headquartered in Bengaluru, India, dedicated to developing affordable, AI-powered small-molecule targeted therapies.
Subscribe to see RenaissThera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
RenaissThera is a biotechnology company headquartered in Bengaluru, India. Its most recent funding round, Seed, closed in July 2026. Xcout tracks 3 named people at RenaissThera, including Ramkesh Meena (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of RenaissThera's closest competitors — see the full list of competitors and alternatives →
RayThera is a small molecule drug discovery company founded in August 2023, headquartered in San Diego, CA, United States. Its mission is to develop safer, more effective therapeutics by advancing drug discovery with proven expertise and adaptable approaches. The company focuses on transformative therapies for unmet medical needs.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Healx is a mission-driven technology company headquartered in Cambridge, United Kingdom, pioneering an AI-native approach to rare disease pharmacology. Founded in 2014, the company focuses on accelerating the discovery and development of treatments for patients left behind by traditional drug development. It operates as a privately held enterprise leveraging advanced artificial intelligence.
ArrePath is a biotechnology research company based in Princeton, New Jersey, focusing on AI-enabled oral small-molecule discovery. The company uses proprietary artificial intelligence and machine learning workflows proven in antibacterial discovery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about RenaissThera? Suggest a correction · Work at RenaissThera? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.